Anti-cancer Effects of MW-03, a Novel Indole Compound, by Inducing 15-Hydroxyprostaglandin Dehydrogenase and Cellular Growth Inhibition in the LS174T Human Colon Cancer Cell Line.
Increases in the expression of prostaglandin E2 (PGE2) are widely known to be involved in aberrant growth in the early stage of colon cancer development. We herein demonstrated that the novel indole compound MW-03 reduced PGE2-induced cAMP formation by catalization to an inactive metabolite by induc...
Main Authors: | , , , , , , , , , , , |
---|---|
Other Authors: | |
Language: | en |
Published: |
PHARMACEUTICAL SOC JAPAN
2017
|
Subjects: | |
Online Access: | http://hdl.handle.net/10150/626040 http://arizona.openrepository.com/arizona/handle/10150/626040 |